Coronary thrombosis, also known as coronary artery thrombosis, is a serious medical condition that occurs when a blood clot forms within the arteries supplying blood to the heart muscle. This condition is a major contributor to heart attacks and can result in severe consequences if not promptly addressed. The coronary arteries play a crucial role in supplying oxygen and nutrients to the heart, enabling it to function efficiently. When a thrombus, or blood clot, obstructs these arteries, it hampers blood flow, leading to an inadequate supply of oxygen to the heart. This deprivation of oxygen can cause damage to the heart muscle and trigger a heart attack. Several risk factors, including atherosclerosis (the buildup of plaque in the arteries), high blood pressure, and smoking, contribute to the development of coronary thrombosis. Prompt medical intervention, such as the use of clot-busting medications or invasive procedures like angioplasty, is essential to restore blood flow and prevent further damage to the heart. Individuals with known risk factors for cardiovascular disease should prioritize preventive measures, such as a healthy lifestyle and regular medical check-ups, to mitigate the risk of coronary thrombosis.
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India